Investor Relations

RSS Content

Vanda Pharmaceuticals Announces Participation at the Citi 12th Annual Biotech Conference

WASHINGTON, Sept. 6, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it will participate at the Citi 12th Annual Biotech Conference. Vanda will host meetings at the Citi Biotech Conference in Boston on Thursday, September 7, 2017.

About Vanda Pharmaceuticals Inc.

Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.

Company Contact:
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-the-citi-12th-annual-biotech-conference-300514948.html

SOURCE Vanda Pharmaceuticals Inc.

  
Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2017 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy